Perioperative chemotherapy with mFOLFOX6 or CAPOX for patients with locally advanced colon cancer (OPTICAL): A multicenter, randomized, phase 3 trial.
Huabin Hu(Sun Yat-sen University), Jigui Chen(Guangxi Medical University), Qingwen Xu(Guangdong Medical College), Jiajun Lai(Shantou University), Ziqiang Wang(Sichuan University), Jiansi Chen(Tumor Hospital of Guangxi Medical University), Zhijie Ding(Johnson & Johnson (United States)), Meijin Huang(Sun Yat-sen University), Yongming Zeng(Shantou University), Yunfeng Li(Jilin University), Jianping Wang(Sun Yat-sen University), Hao Zhang(Dongguan People’s Hospital), Ping Liu(Shanghai University of Traditional Chinese Medicine), Xiaozhong Wang(Shantou Central Hospital), Hongbo Wei(Sun Yat-sen University), Wenbin Chen(Zhejiang University), Ruyi Zhang(Minzu University of China), Haiping Pei(Xiangya Hospital Central South University), Yanhong Deng(Sun Yat-sen University), Zhongcheng Huang(Zhujiang Hospital)
Cited by 30
Related Papers
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
|JAMA|2018|410
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
|Journal of Clinical Oncology|2019|410
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
|Journal of Clinical Oncology|2016|409
BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing
|Nature|2017|402